Literature DB >> 28011889

Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy.

Goutham Talari1, Preetham Talari1, Joseph Sweigart1, Sadiq Ahmed2.   

Abstract

Spontaneous rectus sheath haematomas and cough secondary to losartan are individually rare conditions. Abdominal wall haematomas present with abdominal pain and abdominal mass. Most patients are managed conservatively; Surgery or embolisation is indicated for shock, infection, rupture into the peritoneum or intractable pain. This is a man aged 65 years presented with dry cough and right-sided abdominal pain. He started losartan a few weeks prior to the onset of cough and had been on rivaroxaban for prior deep venous thrombosis. The right side of his abdomen was distended, bruised and tender. His haemoglobin dropped from 13.3to 9.5 g/dL. CT abdomen/pelvis showed a large 14.5×9.1×4.5 cm haematoma within the right lateral rectus muscle. His only risk factor for developing rectus sheath haematoma was cough in the setting of anticoagulation. Dry cough due to angiotensin receptor blockers is rare, but can have very serious consequences. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28011889      PMCID: PMC5237777          DOI: 10.1136/bcr-2016-217801

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Rectus Sheath Hematoma Associated with Apixaban.

Authors:  Kulothungan Gunasekaran; Amanda R McFee Winans; Swetha Murthi; Mudassar Raees Ahmad; Scott Kaatz
Journal:  Clin Pract       Date:  2017-08-01

2.  Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease - a case report.

Authors:  Cheuk-Lik Wong; Clarence Hao-Yu So
Journal:  Thromb J       Date:  2022-10-03

3.  Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report.

Authors:  Elif Börekci
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.